Intravitreal bevacizumab for the treatment of choroidal metastasis

Acta Ophthalmol. 2014 Feb;92(1):e80-2. doi: 10.1111/aos.12285. Epub 2013 Oct 28.

Authors

Min Kim¹, Chang Ho Kim, Hyoung Jun Koh, Sung Chul Lee, Sung Soo Kim

Affiliation

¹ Department of Ophthalmology, Institute of Human Barrier Research, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

PMID: 24165227
DOI: 10.1111/aos.12285

No abstract available

Publication types

Letter

MeSH terms

Aged
Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Bevacizumab
Choroid Neoplasms / diagnosis
Choroid Neoplasms / drug therapy*
Choroid Neoplasms / secondary*
Humans
Intravitreal Injections
Middle Aged
Retinal Detachment / physiopathology
Retrospective Studies
Tomography, Optical Coherence
Treatment Outcome
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Visual Acuity / physiology

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
VEGFA protein, human
Vascular Endothelial Growth Factor A
Bevacizumab